Preview

Нефрология

Расширенный поиск
Доступ открыт Открытый доступ  Доступ закрыт Только для подписчиков

Постконтрастное острое повреждение почек. Обновленные рекомендации комитета по безопасности контрастных средств европейского общества урогенитальной радиологии (ESUR) 2018. Часть 1

https://doi.org/10.24884/1561-6274-2019-23-3-10-20

Полный текст:

Аннотация

Комитет по безопасности контрастных материалов (Contrast Media Safety Committee (CMSC) Европейского общества урогенитальной радиологии (European Society of Urogenital Radiology (ESUR) обновил свои руководящие принципы 2011 года по профилактике постконтрастного острого повреждения почек (ПК-ОПП). Рекомендации основаны на данных обзора литературы. Обновленные руководящие принципы будут представлены в двух частях. В части 1 обсуждаются уточнения терминологии (в частности, отличия ПК-ОПП и контраст индуцированной нефропатии), лучшие способы определения расчетной скорости клубочковой фильтрации (рСКФ). Уточнены факторы риска ПК-ОПП, в том числе при внутривенном и внутриартериальном путях введения контрастного средства. Ключевые положения обновленных рекомендаций: 1) ПК-ОПП является предпочтительным термином для характеристики ухудшения функции почек после введения контрастного средства; 2) ПК-ОПП имеет много причин развития; 3.риск развития ОПП при внутрисосудистом введении контрастного средства, завышен; 4.важными факторами риска для ПК-ОПП являются хроническая болезнь почек и обезвоживание.

Об авторах

Ф. У. Дзгоева
Северо-Осетинская государственная медицинская академия
Россия

Дзгоева Фатима Урузмаговна – профессор, кафедра внутренних болезней №5.

362040, Республика Северная Осетия–Алания, Владикавказ, ул. Пушкинская, д. 40, тел.: 8(918) 822-83-45



О. В. Ремизов
Северо-Осетинская государственная медицинская академия
Россия

Ремизов Олег Валерьевич – профессор, кафедра лучевой диагностики с лучевой терапией и онкологией.

362040, Россия, Республика Северная Осетия–Алания, Владикавказ, ул. Пушкинская, д. 40., тел.: (8672) 530397



Список литературы

1. Stacul F, van der Molen AJ, Reimer P et al. Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011;21:2527–2541. Doi: 10.1007/s00330-011-2225-0

2. Morcos SK, Thomsen HS, Webb JA et al. Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) et al. Dialysis and contrast media. Eur Radiol 2002;12:3026–30303 Doi: 10.1007/s00330-011-2225-0

3. Contrast Media Safety Committee ESUR. Guidelines on Contrast Media v9. CMSC, 2014. Available via: http://www.esurcm.org/index.php/en/ Accessed: 14 December 2017

4. Kooiman J, Seth M, Nallamothu BK et al. Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv 2015; 8:e002212. Doi: 10.1161/CIRCINTERVENTIONS.114.002212

5. Mitchell AM, Kline JA, Jones AE et al. Major adverse events one year after acute kidney injury after contrast-enhanced computed tomography. Ann Emerg Med 2015;66: 267–274. e4. Doi: 10.1016/j.annemergmed.2015.04.028

6. Kooiman J, Pasha SM, Zondag W et al. Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol 2012;81:2554–2561. Doi: 10.1016/j.ejrad.2011.11.020

7. Dong M, Jiao Z, Liu T et al. Effect of administration route on the renal safety of contrast agents: a meta-analysis of randomized controled trials. J Nephrol 2012; 25:290–301. https://www. radiologen.nl/secties/nvvr/documenten/richtlijn-veilig-gebruikvancontrastmiddelen-deel-1-full-english

8. Keeley EC. Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 1998;32:1861–1865. Doi: 10.1016/S07351097(98)00497-5.

9. Wichmann JL, Katzberg RW, Litwin SE et al. Contrastinduced nephropathy. Circulation 2015;132:1931–1936. Doi: 10.1161/CIRCULATIONAHA.115.014672

10. Fananapazir G, Troppmann C, Corwin CK et al. Incidence of contrast-induced nephropathy after renal graft catheter arteriography using iodine-based contrast medium. AJR Am J Roentgenol 2016;206:783–786. Doi: 10.2214/AJR.15.1550177

11. James MT, Samuel SM, Manning MA et al. Contrastinduced acute kidney injury and risk of adverse clinical outcomes after coronary angiography a systematic review and meta-analysis. Circ Cardiovasc Interv 2013;6:37–43. Doi: 10.1161/CIRCINTERVENTIONS.112.974493

12. Kooiman J, Seth M, Nallamothu BK et al. Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions. Circ Cardiovasc Interv 2015;8:e002212. Doi: 10.1161/CIRCINTERVENTIONS.114.002212

13. Feng Y, Huang X, Li L, Chen Z. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.Nephrology (Carlton) 2018;23(6):530–538. Doi: 10.1111/nep.13068

14. Guyatt GH, Oxman AD, Kunz R et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395–400. Doi: 10.1016/j.jclinepi.2010.09.012

15. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. Available via: http://www.cebm.net/index.aspx?o=5653 Accessed 14 December 2017

16. Akrawinthawong K, Ricci J, Cannon L et al. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrastinduced nephropathy (ENCINO), a prospective study. Ren Fail 2015; 37: 187–191. Doi.org/10.1016/j.jacc.2016.05.099

17. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67:2089–2100. Doi: 10.1111/j.1523-1755.2005.00365.x

18. Thongprayoon C, Cheungpasitporn W, Srivali N. AKI after Transcatheter or Surgical Aortic Valve Replacement. J Am Soc Nephrol 2016;27(6):1854–1860. Doi: 10.1681/ASN.2015050577

19. ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media, v10.3. American College of Radiology, 2017 Available via: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf Accessed: 14 December 2017

20. Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013;17:204. Doi: 10.1186/cc11454

21. Pyxaras SA, Zhang Y, Wolf A et al. Effect of varying definitions of contrast-induced acute kidney injury and left ventricular ejection fraction on one-year mortality in patients having transcatheter aortic valve implantation. Am J Cardiol 2015;116:426–430. Doi: 10.1016/j.amjcard.2015.04.056

22. Azzouz M, Rømsing J, Thomsen HS. Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients. Eur J Radiol 2014;83:886–892. Doi: 10.1016/j.ejrad.2014.02.014

23. Garfinkle MA, Stewart S, Basi R. Incidence of CT contrast agent-induced nephropathy: toward a more accurate estimation. AJR Am J Roentgenol 2015;204:1146–1151. Doi: 10.2214/AJR.14.13761

24. Thomas ME, Blaine C, Dawnay A et al. The definition of acute kidney injury and its use in practice. Kidney Int 2015;87:62– 73. Doi: 10.1038/ki.2014.328

25. Nguyen TC, Terwelp MD, Thourani VH, Zhao Y. Clinical trends in surgical, minimally invasive and transcatheter aortic valve replacement. Eur J Cardiothorac Surg 2017; 51(6):1086–1092. Doi: 10.1093/ejcts/ezx008

26. Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012; 27: 4263–4272. Doi: 10.1093/ndt/gfs375

27. Levey AS, Coresh J, Greene T et al. Expressing the MDRD study equation for estimating GFR with standardized serum creatinine values. Clin Chem 2007;53:766–772. Doi: 10.1373/clinchem.2006.077180

28. Sessa M, Rossi C, Mascolo A et al.Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review. Dovepress 2017; 2017: 1463–1478. Doi: https:// Doi.org/10.2147/TCRM.S144418

29. Jeong BY, Lee HY, Park CG et al.Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury. PLoS One 2018 12;13(1):e0191034. Doi: 10.1371/journal.pone.0191034

30. Pottel H, Hoste L, Dubourg L et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 2016;31:798–806. Doi: 10.1093/ndt/gfv454

31. Stevens LA, Li S, Kurella Tamura M et al. Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP) Am J Kidney Dis 2011;57:S9–S16. Doi: 10.1053/j.ajkd.2010.11.007

32. Jurado-Román A, Hernández-Hernández F, GarcíaTejada J et al. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol 2015;115:1174–1178. Doi: 10.1016/j.amjcard.2015.02.004

33. 33. Putzu A, Boscolo Berto M, Belletti A et al. Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: A systematic review and meta-analysis of randomized trials. JACC Cardiovasc Interv 2017;10:355–363. Doi: 10.1016/j.jcin.2016.11.006

34. Solomon R, Gordon P, Manoukian SV et al. Randomized trial of bicarbonate or saline study for the prevention of contrastinduced nephropathy in patients with CKD. Clin J Am Soc Nephrol 2015;10:1519–1524. Doi: 10.2215/CJN.05370514

35. Iranirad L, Hejazi SF, Sadeghi MS, Jang SA.Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial. Cardiol J 2017;24(5):502– 507. Doi: 10.5603/CJ.a2017.0028

36. Vassileva J Rehani M. Diagnostic reference levels. AJR Am J Roentgenol 2015; 204: W1–3. Doi: 10.2214/AJR.14.12794

37. Pauwels R, Cockmartin L, Ivanauskaité D et al. SEDENTEXCT Project Consortium. Estimating cancer risk from dental cone-beam CT exposures based on skin dosimetry. Phys Med Biol 2014; 59: 3877–3891. Doi: 10.1088/0031-9155/59/14/3877

38. McCullough Peter A, ChoicGeorges, Feghali A et al. Contrast-Induced Acute Kidney injury. Journal of the American College of Cardiology 2016; 68: 1465–1473. Doi.org/10.1016/j.jacc.2016.05.099

39. Martinez Lomakin F, Tobar C. Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrastinduced nephropathy: a critical overview. Crit Rev Clin Lab Sci 2014; 51:332–343. Doi: 10.3109/10408363.2014.937794

40. Roh S, Laroia A. Practicing safe use of nonionic, low-osmolarity iodinated contrast. Appl Radiol 2015;44(7):16–19. Doi: 10.1148/radiol.2015151486

41. Nawa T, Nishigaki K, Kinomura Yet al.Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function. Int J Cardiol 2015 15;195:228–234. Doi: 10.1016/j.ijcard.2015.05.078

42. McDonald RJ, McDonald JS, Newhouse JH, Davenport MS. Controversies in contrast material-induced acute kidney injury: closing in on the truth? Radiology 2015;277:627–632. Doi: 10.1148/radiol.2015151486

43. Nyman U, Aspelin P, Jakobsen J, Bjork J. Controversies in contrast material-induced acute kidney injury: Propensity Score matching of patients with different dose/absolute glomerular filtration rate ratios. Radiology 2015;277:633–637. Doi: 10.1148/radiol.2015151341

44. Feng Y, Huang X, Li L, Chen Z. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis. Nephrology (Carlton) 2018; 23(6):530–538. Doi: 10.1111/nep.13068

45. Bei WJ, Duan CY, Chen JY et al. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/ Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol Ther 2016 Jan;21(1):53–63. Doi: 10.1177/1074248415590197

46. Fananapazir G, Troppmann C, Corwin MT et al. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants. Abdom Radiol 2016;41:2182–2186. Doi: 10.1007/s00261-016-0827-3

47. McDonald JS, McDonald RJ, Carter RE et al. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 2014;271:65–73. Doi: 10.1148/radiol.13130775

48. McDonald JS, McDonald RJ, Lieske JC et al. Risk of acute kidney injury, dialysis, and mortality in patients with chronic kidney disease after intravenous contrast material exposure. Mayo Clin Proc 2015;90:1046–1053. Doi: 10.1016/j.mayocp.2015.05.016

49. McDonald JS, Leake CB, McDonald RJ et al. Acute kidney injury after intravenous versus intra-arterial contrast material administration in a paired cohort. Invest Radiol 2016;51:804–809. Doi: 10.1097/RLI.0000000000000298.49

50. Tong GE, Kumar S, Chong KC et al. Risk of contrastinduced nephropathy for patients receiving intravenous vs. intraarterial iodixanol administration. Abdom Radiol 2016;41:91–99. Doi: 10.1007/s00261-015-0611-9

51. Prasad A, Ortiz-Lopez C, Khan A et al. Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv 2016; 88:264–273. Doi: 10.1002/ccd.26466

52. Aubry P, Brillet G, Catella L et al. Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with imageguided cardiovascular procedures. BMC Nephrol 2016;17:167. Doi:10.1186/s12882-016-0385-5

53. Haider M, Yessayan L, Venkat KK et al. Incidence of contrast-induced nephropathy in kidney transplant recipients. Transplant Proc 2015;47:379–383. Doi: 10.1016/j.transproceed.2015.01.008

54. Zuo T, Jiang L, Mao S et al. Hyperuricemia and contrast-induced acute kidney injury: A systematic review and meta-analysis. Int J Cardiol 2016;224:286–294. Doi: 10.1016/j.ijcard.2016.09.033

55. Cantais A, Hammouda Z, Mory O et al. Incidence of contrast-induced acute kidney injury in a pediatric setting: a cohort study. Pediatr Nephrol 2016;31:1355–1362. Doi: 10.1007/s00467-016-3313-9

56. McDonald JS, McDonald RJ, Williamson EE et al. Postcontrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med 2017; 43: 774–784. Doi: 10.1007/s00134-017-4699-y

57. Huggins N, Nugent A, Modem V et al. Incidence of acute kidney injury following cardiac catheterization prior to cardiopulmonary bypass in children. Catheter Cardiovasc Interv 2014; 84: 615–619. Doi: 10.1002/ccd.25405

58. Kanbay M, Solak Y, Afsar B et al. Serum uric acid and risk for acute kidney injury following contrast: an evaluation of epidemiology, clinical trials, and potential mechanisms. Angiology 2017;68:132–144. Doi: 10.1177/0003319716644395

59. Eng J, Wilson RF, Subramaniam RM et al. Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 2016;164:417–424. Doi: 10.7326/M15-1402

60. McDonald JS, McDonald RJ, Williamson EE, Kallmes DF. Is intravenous administration of iodixanol associated with increased risk of acute kidney injury, dialysis, or mortality? a Propensity Score-adjusted study. Radiology 2017:285: 414–424. Doi: 10.1148/radiol.12121460

61. Kooiman J, Seth M, Share D et al. The association between contrast dose and renal complications post-PCI across the continuum of procedural estimated risk. PLoS One 2014;9: e90233. Doi: 10.1371/journal.pone.0090233

62. Yuan Y, Qiu H,, Hu X et al. Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention. Clin Cardiol 2017;40(9):719–725. Doi: 10.1002/clc.22722


Для цитирования:


Дзгоева Ф.У., Ремизов О.В. Постконтрастное острое повреждение почек. Обновленные рекомендации комитета по безопасности контрастных средств европейского общества урогенитальной радиологии (ESUR) 2018. Часть 1. Нефрология. 2019;23(3):10-20. https://doi.org/10.24884/1561-6274-2019-23-3-10-20

For citation:


Dzgoeva F.U., Remizov O.V. Post-Contrast acute kidney injury. Recommendations for updated of the European Society of Urogenital Radiology Contrast Medium Safety Committee guidelines (2018). Part 1. Nephrology (Saint-Petersburg). 2019;23(3):10-20. (In Russ.) https://doi.org/10.24884/1561-6274-2019-23-3-10-20

Просмотров: 172


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)